Global Genetic Analyzer Market

Genetic analysis is a method of learning and research in genetics and molecular biology fields that involves use of wide group of applications while basic system of the analysis is usually pertained to the orthodox genetics. Customary forms of analysis of genetic includes the gene identification and inherited diseases analysis. Genetic analysis also implicit the patients physical observation and the microscopic evaluation of genetics as it is conducted for the long time. Genetic analysis is also applied in differential diagnosis during the analysis of specific diseases, in mutation detection, copy number changes in DNA.

Factors like advancements in the technologies of genetic testing, rise in prevalence of the genetic diseases, growing in the awareness are boosting the genetic analyzer market globally. Furthermore, initiatives taken by the governments and increase in R&D investment and activities in the genetic field are also driving the genetic analyzer market. However, due to certain factors genetic analyzers use is restricted. The operability of such kind of automated advanced machines requires technical expertise leaving little room for human error. Calibration is essentially needed for genetic analyzers. High cost of genetic analyzers resulting in their availability in a limited number of research organizations is also hampering the growth of the genetic analyzers market globally.

Global genetic analyzer market is segmented on the basis of instruments, consumables, application, end-user and geographical regions.

Based on product type, global genetic analyzer market is segmented as:

• Instruments
  • DNA Microarrays
  • PCR
  • Next Generation Sequencing
  • Serial Analysis of Gene Expression
  • Northern Blotting
• Consumables
  • DNA Chips
  • Reagents

Based on the end-user, global genetic analyzer market is segmented as:

• Diagnostics Centres
• Drug Discovery
• Research and Development
• Others

Increase in the clinical genome sequencing, increase in incidence of neurodegeneration diseases such as Alzheimer’s, Huntington’s and Parkinson’s disease and also cases of cancers prompts the interest in genetic analysis. High swift in the acceptance of pediatric genetic testing used for of screening adult onset disorders are the factors contributing to the genetic analyzer market growth. Some of the government initiatives are improving the healthcare delivery to different sections of population, mergers, acquisitions and product launches of the companies are the factors driving the growth of the genetic analyzer market.

Geographically, genetic analyzer market is divided into Europe, Asia-Pacific North America, Latin America, and Middle East and Africa. Global genetic analyser market is dominated by North America due to the rise in diseases prevalence by genetic disorders and rise in advancements technologically in the region. Asia-Pacific, is expected to show significant growth during the forecast period in the genetic testing market. India, China and Japan are expected as the fastest growing genetic testing markets in the Asia-Pacific region due to increase in R&D investment, a large pool of patients and rising government funding.

Some of the major companies dealing in genetic testing market are Thermo Fisher Scientific Inc. (U.S.), BioRad Laboratories (U.S.), Abbott laboratories (U.S.), AutoGenomics Inc.( U.S.), Celera Group (U.S.), PerkinElmer Inc.( U.S.), Quest Diagnostics Inc.( U.S.), ELITech Group (U.S.), Applied Biosystems Inc.( U.S.), F. Hoffmann-La Roche AG (Switzerland), Transgenomic Inc.( U.S.).

• In May 2017, Thermo Fisher Scientific launched its Applied Biosystems SeqStudio Genetic Analyzer, a new capillary electrophoresis system which can be used for plasmid sequencing, species identification, human cell authentication and research in oncology

Report Outline:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

1. Executive Summary
2. Global Genetic Analyzer Market Introduction
2.1. Global Genetic Analyzer Market – Taxonomy
2.2. Global Genetic Analyzer Market –Definitions
2.2.1. Product Type
2.2.2. End-User
3. Global Genetic Analyzer Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Genetic Analyzer Market Dynamics – Factors Impact Analysis
3.6. Global Genetic Analyzer Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
4. Global Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Genetic Analyzer Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Instruments
5.1.1. DNA Microarrays
5.1.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. PCR
5.1.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Next Generation Sequencing
5.1.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Serial Analysis of Gene Expression
5.1.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Northern Blotting
5.1.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Consumables
5.2.1. DNA Chips
5.2.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Reagents
5.2.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
6. Global Genetic Analyzer Market Forecast, By End-User, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Hospital Pharmacies
6.2. Diagnostics Centres
6.3. Drug Discovery
6.4. Research and Development
6.5. Others
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Genetic Analyzer Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Region, 2018 – 2024
8. North America Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Instruments
8.1.1.1. DNA Microarrays
8.1.1.2. PCR
8.1.1.3. Next Generation Sequencing
8.1.1.4. Serial Analysis of Gene Expression
8.1.1.5. Northern Blotting
8.1.2. Consumables
8.1.2.1. DNA Chips
8.1.2.2. Reagents
8.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Diagnostics Centres
8.2.2. Drug Discovery
8.2.3. Research and Development
8.2.4. Others
8.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
8.5. North America Genetic Analyzer Market Dynamics – Trends
9. Europe Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
9.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Instruments
9.1.1.1. DNA Microarrays
9.1.1.2. PCR
9.1.1.3. Next Generation Sequencing
9.1.1.4. Serial Analysis of Gene Expression
9.1.1.5. Northern Blotting
9.1.2. Consumables
9.1.2.1. DNA Chips
9.1.2.2. Reagents
9.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Diagnostics Centres
9.2.2. Drug Discovery
9.2.3. Research and Development
9.2.4. Others
9.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
9.5. Europe Genetic Analyzer Market Dynamics – Trends
10. Asia-Pacific Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.1.1. DNA Microarrays
10.1.1.2. PCR
10.1.1.3. Next Generation Sequencing
10.1.1.4. Serial Analysis of Gene Expression
10.1.1.5. Northern Blotting
10.1.2. Consumables
10.1.2.1. DNA Chips
10.1.2.2. Reagents
10.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Diagnostics Centres
10.2.2. Drug Discovery
10.2.3. Research and Development
10.2.4. Others
10.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
10.5. Asia-Pacific Genetic Analyzer Market Dynamics – Trends
11. Latin America Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.1.1. DNA Microarrays
11.1.1.2. PCR
11.1.1.3. Next Generation Sequencing
11.1.1.4. Serial Analysis of Gene Expression
11.1.1.5. Northern Blotting
11.1.2. Consumables
11.1.2.1. DNA Chips
11.1.2.2. Reagents
11.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Diagnostics Centres
11.2.2. Drug Discovery
11.2.3. Research and Development
11.2.4. Others
11.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
11.5. Latin America Genetic Analyzer Market Dynamics – Trends
12. Middle East and Africa Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.1.1. DNA Microarrays
12.1.1.2. PCR
12.1.1.3. Next Generation Sequencing
12.1.1.4. Serial Analysis of Gene Expression
12.1.1.5. Northern Blotting
12.1.2. Consumables
12.1.2.1. DNA Chips
12.1.2.2. Reagents
12.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Diagnostics Centres
12.2.2. Drug Discovery
12.2.3. Research and Development
12.2.4. Others
12.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
12.5. MEA Genetic Analyzer Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Thermo Fisher Scientific Inc. (U.S.)
13.2.2. BioRad Laboratories (U.S.)
13.2.3. Abbott Laboratories (U.S.)
13.2.4. AutoGenomics Inc. (U.S.)
13.2.5. Celera Group (U.S.)
13.2.6. PerkinElmer Inc. (U.S.)
13.2.7. Quest Diagnostics Inc. (U.S.)
13.2.8. ELITech Group (U.S.)
13.2.9. Applied Biosystems Inc. ( U.S.)
13.2.10. F. Hoffmann-La Roche AG (Switzerland)
13.2.11. Transgenomic Inc.( U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

ASK AN ANALYST

Request Customisation